New blood markers could spot sepsis in newborns faster

NCT ID NCT07635264

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether combining standard blood markers (like CRP and PCT) with newer ones (like immature granulocytes and platelet ratios) could more accurately diagnose late-onset sepsis in full-term newborns. Researchers reviewed data from 128 babies to see how well these tests worked over time. The goal is to help doctors diagnose serious infections faster and more reliably.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION INDICES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neonatal Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mersin University

    Mersin, 33310, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.